Report Scope:
The “Market at a Glance Pharmaceuticals” provides a sampling of the market share in key therapeutics of pharmaceutical industry that has been aiding business decision making since the inception of BCC Research in 1971. It includes the market share and company profiles of leading players on the following markets -

  • Active Pharmaceutical Ingredients: Global Markets to 2022 (PHM200A).
  • Antipsychotic Drugs: Technologies and Global Markets (PHM063B).
  • Brain Tumor Therapeutics: Global Markets to 2023 (PHM208A).
  • Clinical Nutrition: Global Markets to 2022 (PHM198A).
  • Diagnostics and Therapeutics for HIV: Global Markets (PHM058C).
  • Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions (PHM177B).
  • The Global Influenza Market (PHM049E).
  • Global Markets for Treatment and Diagnosis of Sexually Transmitted Diseases (PHM005D).
  • Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging (PHM043G).
  • Global Markets for Infectious Disease Treatments (PHM061D).
  • Neuroprotective Agents: Therapeutic Applications and Global Markets (PHM188A).

Report Includes:

  • Examination of trends revolutionizing the pharmaceuticals sector
  • An overview of Active Pharmaceutical Ingredients (API), antipsychotic drugs, and neuroprotective agents
  • Information on Alnylam’s RNAi drug Onpattro, used to treat nerve damage from hereditary transthyretin-mediated amyloidosis
  • Details pertaining to market share and company profiles of leading players of the industry